[HTML][HTML] In vitro activity of tigecycline and colistin against clinical isolates of Acinetobacter baumannii in hospitals in Tehran and Bandar-Abbas, Iran

A Karmostaji, S Javadpour, P Davoodian… - Electronic …, 2014 - ncbi.nlm.nih.gov
Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of
the main causes of nosocomial infections in recent years. The high prevalence of drug …

[PDF][PDF] Emergence of Tigecycline resistant Acinetobacter baumannii from an intensive care unit (ICU) in Tehran

A Karmostaj, PS NAJAR, AH Salmanian - 2013 - sid.ir
Background: Acinetobacter species, specially, Acinetobacter baumannii, is known, as an
important opportunistic pathogen, with a variety of infections such as pneumonia …

[HTML][HTML] Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii

IA Kaya, MD Guner, G Akca, S Tuncbilek… - Pakistan journal of …, 2017 - ncbi.nlm.nih.gov
Objective: Acinetobacter baumannii species cause nosocomial infections and can
subsequently develop multidrug resistance (MDR). The objective of this study was to …

Growing OXA-23 type strains among carbapenem-resistant Acinetobacter baumannii and tigecycline as an alternate combination therapy

Ş Altun, ZK Tufan, B Altun, U Önde… - Turkish Journal of …, 2016 - journals.tubitak.gov.tr
Background/aim: The increasing prevalence and global spread of difficult-to-treat
carbapenem-resistant Acinetobacter baumannii has become a serious problem. The aim of …

In vitro activity of tigecycline against Acinetobacter baumannii strains isolated from nosocomial infections

E Akinci, İ MUMCUOĞLU… - Turkish Journal of …, 2008 - journals.tubitak.gov.tr
Aims: Acinetobacter species usually affect hospitalized patients and are involved in many
infections associated with a high mortality rate. Management of infections caused by these …

[PDF][PDF] Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period

AM Baadani, SI Thawadi, NA El-Khizzi, AS Omrani - Saudi Med J, 2013 - researchgate.net
Objectives: To describe the rates and patterns of colistin and tigecycline resistance among
Acinetobacter baumannii (A. baumannii) isolates from clinical specimens from 2 major …

Determination of colistin and tigecycline resistance profile of Acinetobacter baumannii strains from different clinical samples in a territory hospital in Turkey

M Şimşek, C Demir - 2020 - acikerisim.afsu.edu.tr
Objective: Acinetobacter baumannii (A. baumannii) can develop resistance to various
antimicrobial agents via different mechanisms. Hence, the aim of this study was to …

[PDF][PDF] In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates

R Ricciardi, AM Ricciardi, G Danzi - Infez Med, 2009 - infezmed.it
Acinetobacter baumannii is an important op-portunistic pathogen that is rapidly evolving
toward multidrug resistance (MDR) and is involved in various nosocomial infections …

[PDF][PDF] ACINETOBACTER BAUMANNII SUŞLARINDA TİGESİKLİN ETKİNLİĞİNİN ARAŞTIRILMASI

Y ZER¹, FEÖ AKIN… - İnfeksiyon Dergisi (Turkish …, 2007 - infeksiyon.dergisi.org
Acinetobacter baumannii is a frequent cause nosocomial infections in most hospitals. It is
isolated as an agent of bacteremia, seconder meningitis, urinary tract infection, late …

In vitro tigecycline and carbapenem susceptibilities of clinical isolates of Acinetobacter baumannii

S NAYMAN ALPAT, A Aybey, F Aksit… - MIKROBIYOLOJI …, 2010 - avesis.ogu.edu.tr
Acinetobacter baumannii is a frequent cause of nosocomial infections in most hospitals.
Management of infections caused by these strains is difficult, as the strains often display …